Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics
Ahmed M Fatouh,1 Ahmed H Elshafeey,1,2 Ahmed Abdelbary1 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2School of Pharmacy, University of Waterloo, Waterloo, ON, Canada Purpose: Agomelatine is a novel antidepressant drug suffering from an e...
Saved in:
Main Authors: | Fatouh AM (Author), Elshafeey AH (Author), Abdelbary A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Agomelatine-based in situ gels for brain targeting via the nasal route: statistical optimization, in vitro, and in vivo evaluation
by: Ahmed M. Fatouh, et al.
Published: (2017) -
Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery
by: Thi-, et al.
Published: (2022) -
Transdermal agomelatine microemulsion gel: pyramidal screening, statistical optimization and in vivo bioavailability
by: Mayada Said, et al.
Published: (2017) -
Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
by: Cláudia Pina Costa, et al.
Published: (2021) -
Solid lipid nanoparticles of irbesartan: preparation, characterization, optimization and pharmacokinetic studies
by: Deepthi Soma, et al.
Published: (2017)